Clinical Trials

Keywords/SWOG Study Number

Area of Research

Accrual Status

Any

Open

Closed

Limit to SWOG Trials

All Trials

SWOG Trials Only

Show only published studies

Study Type

Treatment

Study Chair

Participating Institution

Phase

Cancer Control Subcommittee

Study Sponsor

FDA Registration Trial

Uses PRO Forms

1040 Results

View

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-8897

Comparison of Adjuvant Chemotherapy With or Without Endocrine Therapy in High-Risk, Node Negative Breast Cancer Patients, and a Natural History Follow-up Study in Low-Risk Node Negative Patients (to initially low risk patients)

Research Committee(s)

Breast Cancer

Activated

07-15-1989

Closed

02-01-1993

Closed

Phase

Accrual

46%

Published

SWOG Clinical Trial Number

SWOG-8907

A Phase ll Trial of Combination Chemotherapy Plus Verapamil in Drug Refractory Intermediate Grade and Selected High Grade Non-Hodgkin's Lymphomas

Activated

07-01-1989

Closed

12-15-1991

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-8925

Evaluations of Cisplatin + VP-16 Followed by Mitotane at Progression if No Prior Mitotane or Cisplatin + VP-16 Only if Prior Treatment with Mitotane in Advanced and Metastatic Adrenal Cortical Carcinoma

Research Committee(s)

Genitourinary Cancer

Activated

06-15-1989

Closed

12-01-1995

Closed

Phase

Accrual

50%

SWOG Clinical Trial Number

SWOG-8816

Study of 13-cis Retinoic Acid (Accutane) Plus rIFN-A (Roferon-A) in Mycosis Fungoides

Activated

05-15-1989

Closed

01-01-1993

Closed

Phase

Accrual

71%

Published

SWOG Clinical Trial Number

SWOG-8892 (INT-0099) (EST-2388) (RTOG-8817)

A Study of Radiotherapy With or Without Concurrent Cisplatin in Patients with Nasopharyngeal Cancer

Research Committee(s)

Head and Neck Cancer

Activated

05-15-1989

Closed

12-01-1995

Closed

Phase

Accrual

77%

Published

SWOG Clinical Trial Number

SWOG-8807

An Investigation of the Relationship Between an Integrated, System Education Approach and Breast Self Exam (BSE) Compliance

Research Committee(s)

Breast Cancer

Activated

05-15-1989

Closed

12-01-1993

Closed

Phase

Accrual

88%

Published

SWOG Clinical Trial Number

SWOG-8833

Phase ll Investigation of Chlorambucil and Fludarabine Monophosphate in Relapsed or Refractory Chronic Lymphocytic Leukemia

Activated

05-15-1989

Closed

04-15-1991

Closed

Phase

SWOG Clinical Trial Number

SWOG-8854

Prognostic Value of Cytometry Measurements of Breast Cancer DNA From Postmenopausal Patients With Involved Nodes and Receptor Positive Tumors: A Companion Protocol to SWOG-8814

Activated

05-15-1989

Closed

02-15-1995

Closed

Phase

Accrual

36%

Published

SWOG Clinical Trial Number

SWOG-8812

Treatment of Limited Small Cell Lung Cancer with Concurrent Chemotherapy, Radiotherapy, With or Without GM-CSF and Subsequent Randomization to Maintenance Interferon or No Maintenance

Activated

05-15-1989

Closed

01-01-1992

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-8814

Phase lll Comparison of Adjuvant Chemoendocrine Therapy with CAF and Concurrent or Delayed Tamoxifen to Tamoxifen Alone in Postmenopausal Patients with Involved Axillary Lymph Nodes and Positive Receptors (Intergroup)

Research Committee(s)

Breast Cancer

Activated

05-15-1989

Closed

08-01-1995

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-8900

A Phase II Pilot of VAD and VAD/Verapamil for Refractory Multiple Myeloma

Activated

05-01-1989

Closed

12-01-1991

Closed

Phase

Accrual

SWOG Clinical Trial Number

SWOG-8822

A Phase II Study of Continuous Infusion Recombinant Interleukin-2 (r-IL-2) in Patients with Malignant Lymphoma

Activated

05-01-1989

Closed

06-15-1991

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-8824

A Phase II Study of Continuous Infusion Recombinant Interleukin-2 (rIL-2) in Patients with Advanced Renal Cell Carcinoma

Activated

05-01-1989

Closed

08-15-1991

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-8708

Treatment of Hormonally Refractory Stage D Carcinoma of the Prostate with CHIP

Activated

04-01-1989

Closed

09-01-1990

Closed

Phase

Accrual

10%

SWOG Clinical Trial Number

SWOG-8830

A Phase II Study of Continuous Infusion Recombinant Interleukin-2 (rIL-2) in Patients with Ovarian Cancer

Activated

04-01-1989

Closed

11-15-1990

Closed

Phase

Accrual

SWOG Clinical Trial Number

SWOG-8832

A Phase II Study of Continuous Infusion Recombinant Interleukin-2 (rIL-2) in Patients with Pancreatic Cancer

Activated

04-01-1989

Closed

11-15-1990

Closed

Phase

Accrual

14%

SWOG Clinical Trial Number

SWOG-8823

Phase II Study of Continuous Infusion Recombinant Interleukin-2 (r-IL2) in Patients with Colorectal Carcinoma

Activated

04-01-1989

Closed

11-15-1990

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-8836

Study of Chest Irradiation Plus Concurrent Daily Low- Dose Cisplatin Followed by High Dose Cisplatin Consolidation for Locally Advanced Non-Small Cell Lung Cancer

Activated

04-01-1989

Closed

05-15-1991

Closed

Phase

Accrual

97%

Published

SWOG Clinical Trial Number

SWOG-8829

Evaluation of Amonafide in the Treatment of CNS Tumors

Activated

03-15-1989

Closed

12-01-1990

Closed

Phase

Accrual

SWOG Clinical Trial Number

SWOG-8791 (INT-0087)

Adjuvant Trial of Soft Tissue Sarcomas

Activated

03-01-1989

Closed

12-01-1990